1	Inhibition	Inhibition	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	human	human	_	_	_	_	_	_	_
4	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
5	virus	virus	_	_	_	_	_	_	_
6	type	type	_	_	_	_	_	_	_
7	1	1	_	_	_	_	_	_	_
8	replication	replication	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	vitro	vitro	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	a	a	_	_	_	_	_	_	_
13	novel	novel	_	_	_	_	_	_	_
14	combination	combination	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	anti-Tat	anti-tat	_	_	_	_	_	_	_
17	single-chain	single-chain	_	_	_	_	_	_	_
18	intrabodies	intrabody	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	NF-kappa	NF-kappa	_	_	_	_	_	_	_
21	B	B	_	_	_	_	_	_	_
22	antagonists	antagonist	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Human	human	_	_	_	_	_	_	_
2	immunodeficiency	immunodeficiency	_	_	_	_	_	_	_
3	virus	virus	_	_	_	_	_	_	_
4	type	type	_	_	_	_	_	_	_
5	1	1	_	_	_	_	_	_	_
6	(	(	_	_	_	_	_	_	_
7	HIV-1	HIV-1	_	_	_	_	_	_	_
8	)	)	_	_	_	_	_	_	_
9	Tat	Tat	_	_	_	_	_	_	_
10	,	,	_	_	_	_	_	_	_
11	an	an	_	_	_	_	_	_	_
12	early	early	_	_	_	_	_	_	_
13	regulatory	regulatory	_	_	_	_	_	_	_
14	protein	protein	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	is	be	_	_	_	_	_	_	_
17	critical	critical	_	_	_	_	_	_	_
18	for	for	_	_	_	_	_	_	_
19	viral	viral	_	_	_	_	_	_	_
20	gene	gene	_	_	_	_	_	_	_
21	expression	expression	_	_	_	_	_	_	_
22	and	and	_	_	_	_	_	_	_
23	replication	replication	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	transactivates	transactivate	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	HIV-1	HIV-1	_	_	_	_	_	_	_
28	long	long	_	_	_	_	_	_	_
29	terminal	terminal	_	_	_	_	_	_	_
30	repeat	repeat	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	LTR	LTR	_	_	_	_	_	_	_
33	)	)	_	_	_	_	_	_	_
34	via	via	_	_	_	_	_	_	_
35	its	its	_	_	_	_	_	_	_
36	binding	binding	_	_	_	_	_	_	_
37	to	to	_	_	_	_	_	_	_
38	the	the	_	_	_	_	_	_	_
39	transactivation	transactivation	_	_	_	_	_	_	_
40	response	response	_	_	_	_	_	_	_
41	element	element	_	_	_	_	_	_	_
42	(	(	_	_	_	_	_	_	_
43	TAR	TAR	_	_	_	_	_	_	_
44	)	)	_	_	_	_	_	_	_
45	and	and	_	_	_	_	_	_	_
46	,	,	_	_	_	_	_	_	_
47	along	along	_	_	_	_	_	_	_
48	with	with	_	_	_	_	_	_	_
49	other	other	_	_	_	_	_	_	_
50	cellular	cellular	_	_	_	_	_	_	_
51	factors	factor	_	_	_	_	_	_	_
52	,	,	_	_	_	_	_	_	_
53	increases	increase	_	_	_	_	_	_	_
54	viral	viral	_	_	_	_	_	_	_
55	transcription	transcription	_	_	_	_	_	_	_
56	initiation	initiation	_	_	_	_	_	_	_
57	and	and	_	_	_	_	_	_	_
58	elongation	elongation	_	_	_	_	_	_	_
59	.	.	_	_	_	_	_	_	_

1	Tat	Tat	_	_	_	_	_	_	_
2	also	also	_	_	_	_	_	_	_
3	superactivates	superactivate	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	HIV-1	HIV-1	_	_	_	_	_	_	_
6	promoter	promoter	_	_	_	_	_	_	_
7	through	through	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	TAR-independent	tar-independent	_	_	_	_	_	_	_
10	mechanism	mechanism	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	including	include	_	_	_	_	_	_	_
13	tumor	tumor	_	_	_	_	_	_	_
14	necrosis	necrosis	_	_	_	_	_	_	_
15	factor	factor	_	_	_	_	_	_	_
16	alpha-induced	alpha-induced	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	protein	protein	_	_	_	_	_	_	_
19	kinase	kinase	_	_	_	_	_	_	_
20	C	C	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	PKC)-dependent	pkc)-dependent	_	_	_	_	_	_	_
23	activation	activation	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	NF-kappa	NF-kappa	_	_	_	_	_	_	_
26	B	B	_	_	_	_	_	_	_
27	,	,	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	inhibitors	inhibitor	_	_	_	_	_	_	_
30	of	of	_	_	_	_	_	_	_
31	Tat	Tat	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	NF-kappa	NF-kappa	_	_	_	_	_	_	_
34	B	B	_	_	_	_	_	_	_
35	cooperatively	cooperatively	_	_	_	_	_	_	_
36	down-regulate	down-regulate	_	_	_	_	_	_	_
37	this	this	_	_	_	_	_	_	_
38	Tat-mediated	tat-mediated	_	_	_	_	_	_	_
39	LTR	LTR	_	_	_	_	_	_	_
40	superactivation	superactivation	_	_	_	_	_	_	_
41	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	this	this	_	_	_	_	_	_	_
3	study	study	_	_	_	_	_	_	_
4	,	,	_	_	_	_	_	_	_
5	a	a	_	_	_	_	_	_	_
6	combined	combined	_	_	_	_	_	_	_
7	pharmacologic	pharmacologic	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	genetic	genetic	_	_	_	_	_	_	_
10	strategy	strategy	_	_	_	_	_	_	_
11	using	use	_	_	_	_	_	_	_
12	two	two	_	_	_	_	_	_	_
13	PKC	PKC	_	_	_	_	_	_	_
14	(	(	_	_	_	_	_	_	_
15	NF-kappa	NF-kappa	_	_	_	_	_	_	_
16	B	B	_	_	_	_	_	_	_
17	)	)	_	_	_	_	_	_	_
18	inhibitors	inhibitor	_	_	_	_	_	_	_
19	,	,	_	_	_	_	_	_	_
20	pentoxifylline	pentoxifylline	_	_	_	_	_	_	_
21	(	(	_	_	_	_	_	_	_
22	PTX	PTX	_	_	_	_	_	_	_
23	)	)	_	_	_	_	_	_	_
24	and	and	_	_	_	_	_	_	_
25	Go-6976	Go-6976	_	_	_	_	_	_	_
26	,	,	_	_	_	_	_	_	_
27	and	and	_	_	_	_	_	_	_
28	a	a	_	_	_	_	_	_	_
29	stably	stably	_	_	_	_	_	_	_
30	expressed	express	_	_	_	_	_	_	_
31	anti-Tat	anti-tat	_	_	_	_	_	_	_
32	single-chain	single-chain	_	_	_	_	_	_	_
33	intracellular	intracellular	_	_	_	_	_	_	_
34	antibody	antibody	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	sFv	sfv	_	_	_	_	_	_	_
37	intrabody	intrabody	_	_	_	_	_	_	_
38	)	)	_	_	_	_	_	_	_
39	was	be	_	_	_	_	_	_	_
40	employed	employ	_	_	_	_	_	_	_
41	to	to	_	_	_	_	_	_	_
42	obtain	obtain	_	_	_	_	_	_	_
43	cooperative	cooperative	_	_	_	_	_	_	_
44	inhibition	inhibition	_	_	_	_	_	_	_
45	of	of	_	_	_	_	_	_	_
46	both	both	_	_	_	_	_	_	_
47	HIV-1	HIV-1	_	_	_	_	_	_	_
48	LTR-driven	ltr-driven	_	_	_	_	_	_	_
49	gene	gene	_	_	_	_	_	_	_
50	expression	expression	_	_	_	_	_	_	_
51	and	and	_	_	_	_	_	_	_
52	HIV-1	HIV-1	_	_	_	_	_	_	_
53	replication	replication	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	Treatment	Treatment	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	with	with	_	_	_	_	_	_	_
5	PTX	PTX	_	_	_	_	_	_	_
6	and	and	_	_	_	_	_	_	_
7	Go-6976	Go-6976	_	_	_	_	_	_	_
8	resulted	result	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	cooperative	cooperative	_	_	_	_	_	_	_
11	inhibition	inhibition	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	both	both	_	_	_	_	_	_	_
14	HIV-1	HIV-1	_	_	_	_	_	_	_
15	LTR-driven	ltr-driven	_	_	_	_	_	_	_
16	gene	gene	_	_	_	_	_	_	_
17	expression	expression	_	_	_	_	_	_	_
18	and	and	_	_	_	_	_	_	_
19	HIV-1	HIV-1	_	_	_	_	_	_	_
20	replication	replication	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	addition	addition	_	_	_	_	_	_	_
3	,	,	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	combined	combined	_	_	_	_	_	_	_
6	use	use	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	anti-Tat	anti-tat	_	_	_	_	_	_	_
9	sFv	sfv	_	_	_	_	_	_	_
10	intrabodies	intrabody	_	_	_	_	_	_	_
11	and	and	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	two	two	_	_	_	_	_	_	_
14	NF-kappa	NF-kappa	_	_	_	_	_	_	_
15	B	B	_	_	_	_	_	_	_
16	inhibitors	inhibitor	_	_	_	_	_	_	_
17	retained	retain	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	virus	virus	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	latent	latent	_	_	_	_	_	_	_
23	state	state	_	_	_	_	_	_	_
24	for	for	_	_	_	_	_	_	_
25	as	as	_	_	_	_	_	_	_
26	long	long	_	_	_	_	_	_	_
27	as	as	_	_	_	_	_	_	_
28	45	45	_	_	_	_	_	_	_
29	days	day	_	_	_	_	_	_	_
30	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	combined	combined	_	_	_	_	_	_	_
3	treatment	treatment	_	_	_	_	_	_	_
4	resulted	result	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	more	more	_	_	_	_	_	_	_
7	durable	durable	_	_	_	_	_	_	_
8	inhibition	inhibition	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	HIV-1	HIV-1	_	_	_	_	_	_	_
11	replication	replication	_	_	_	_	_	_	_
12	than	than	_	_	_	_	_	_	_
13	was	be	_	_	_	_	_	_	_
14	seen	see	_	_	_	_	_	_	_
15	with	with	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	NF-kappa	NF-kappa	_	_	_	_	_	_	_
18	B	B	_	_	_	_	_	_	_
19	inhibitors	inhibitor	_	_	_	_	_	_	_
20	alone	alone	_	_	_	_	_	_	_
21	or	or	_	_	_	_	_	_	_
22	the	the	_	_	_	_	_	_	_
23	anti-Tat	anti-tat	_	_	_	_	_	_	_
24	sFv	sfv	_	_	_	_	_	_	_
25	intrabodies	intrabody	_	_	_	_	_	_	_
26	alone	alone	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

1	Together	together	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	results	result	_	_	_	_	_	_	_
5	suggest	suggest	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	future	future	_	_	_	_	_	_	_
9	clinical	clinical	_	_	_	_	_	_	_
10	gene	gene	_	_	_	_	_	_	_
11	therapy	therapy	_	_	_	_	_	_	_
12	trials	trial	_	_	_	_	_	_	_
13	,	,	_	_	_	_	_	_	_
14	a	a	_	_	_	_	_	_	_
15	combined	combined	_	_	_	_	_	_	_
16	pharmacologic	pharmacologic	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	genetic	genetic	_	_	_	_	_	_	_
19	strategy	strategy	_	_	_	_	_	_	_
20	like	like	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	one	one	_	_	_	_	_	_	_
23	reported	report	_	_	_	_	_	_	_
24	here	here	_	_	_	_	_	_	_
25	may	may	_	_	_	_	_	_	_
26	improve	improve	_	_	_	_	_	_	_
27	the	the	_	_	_	_	_	_	_
28	survival	survival	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	transduced	transduce	_	_	_	_	_	_	_
31	cells	cell	_	_	_	_	_	_	_
32	and	and	_	_	_	_	_	_	_
33	prolong	prolong	_	_	_	_	_	_	_
34	clinical	clinical	_	_	_	_	_	_	_
35	benefit	benefit	_	_	_	_	_	_	_
36	.	.	_	_	_	_	_	_	_

